Abstracts/Presentations

  1. Tornatore K., Brazeau D., Meaney C., Attwood K., Wilding G., Chang S., Venuto R. Association of CYP3A5*3*6*7 Metabolic Composites to Tacrolimus Pharmacokinetics in African American and Caucasian Renal Transplant Recipients Am J Transplant. 2018;18 (suppl 4).
  2. Tornatore K., Attwood K., Brazeau D., Chang S., Venuto R. Target Tacrolimus Troughs and CYP3A5 Polymorphisms Do Not Predict Therapeutic Drug Exposure in African American and Caucasian Renal Transplant Recipients Am J Transplant. 2018;18 (suppl 4).
  3. Tornatore KM,  Attwood  K, Venuto RC;  Age Influences on Tacrolimus Pharmacokinetics Post-transplant American Society of Nephrology Annual Meeting 2017; JASN: Vol 29(Suppl)  Abstract # 2787423 Session Title: 1601-PO01 Pharmacokinetics, Pharmacodynamics, Pharmacogenomics; November 4, 2017; New Orleans, LA.
  4. Chen S, PharmD, Tornatore K, Brazeau D, Warner J, Venuto R: Association of Cytochrome P450 3A4*1beta Genotype and Tacrolimus Pharmacokinetics in Stable African American and Caucasian renal transplant patients; American College of Clinical Pharmacy Annual Meeting; October 7-10, 2017 Abstract #: 43072; Pharmacotherapy  September 2017, Phoenix AZ (ACCP PharmD Student Finalist for Outstanding Research Project)
  5. Campagne O, Mager DE, Brazeau D, Venuto RC, Tornatore KM; Tacrolimus Population Pharmacokinetics And CYP 3A5 Genotypes In African American And Caucasian Renal Transplant Recipients. American Society of Clinical Pharmacology and Therapeutics (ASCPT) 2017; Clinical Pharmacology & Therapeutics 2017; 101(S1):E30: March 15, 2017; Washington, DC (ASCPT Showcase Top Trainee and Poster Walk).
  6. Tornatore KM, Attwood K, Cooper LM, Venuto, RC; Influence of Age and Race on Mycophenolic Acid Pharmacokinetics Post-transplant; American Society of Nephrology Annual Meeting 2016; November 19, 2016; JASN: Vol 28(Suppl): #2851 Abstract.
  7. Tornatore KM, Brazeau D, Wilding GE, Cooper LM, Venuto RC.CYP 3A5 Genotype and Race Association to Tacrolimus Pharmacokinetics; American Society of Nephrology Annual Meeting 2016; November 19, 2016; JASN: Vol 28(Suppl): #2845 Abstract.
  8. Tornatore KM, Attwood K, McGuire O, O'Loughlin K, Venuto RC, Minderman H. Nuclear Factor of Activated T-cells Post-Renal Transplant; American Transplant Congress 2016; Poster Session II: Kidney Complications-Other:  American Journal of Transplantation 2016 16(Supplement); presented June 14, 2016;  Presentation #: 998 (Poster).
  9. Tornatore KM, Minderman H, Attwood K, O'Loughlin K, Venuto RC. P-glycoprotein function: Association with Race, Gender and Tacrolimus Pharmacokinetics. American Transplant Congress 2016; Concurrent Session: Medication Errors, Variability and Adherence:  American Journal of Transplantation 2016 16(Supplement); presented June 13, 2016; Presentation #: 335 (Platform Presentation).
  10. Tornatore KM, Meaney  CJ, Wilding GE, Chang SS, Gundroo A, Cooper LM, Gray V,  Shin KN, Fetterly GJ,  Prey JJ,  Clark K,  Venuto RC. Influence Of Sex And Race On Mycophenolic Acid Pharmacokinetics In Stable African American And Caucasian Renal Transplant Recipients; American Society of Clinical Pharmacology and Therapeutics(ASCPT) 2016; Clinical Pharmacology & Therapeutics 2016 98(S1):E30: March 9, 2016; San Diego, CA  (Encore Poster).
  11. Tornatore  KM, Brazeau D, Meaney CJ, Cooper LM, Venuto RC. Sex and ABCB1 Haplotype Associations with Tacrolimus Pharmacokinetics in Renal Transplant Recipients. American Society of Nephrology annual Meeting 2015; November 7, 2015; JASN: Vol 26(Suppl)  (Poster).
  12. Tornatore KM, Meaney CJ, Consiglio JD, Wilding G, Chang SS, Venuto RC. Sex And Race Influences on Tacrolimus Pharmacokinetics in Renal Transplant Recipients: American Society of Nephrology annual Meeting 2015; November 7, 2015; JASN: Vol 26(Suppl) Nov 2015 (Poster).
  13. Tornatore KM, Minderman H, McQuire O, O'Loughlin K, Shan G, Wilding G, Venuto RC.    Nuclear Localization of Nuclear Factor of Activated T-cells as a Pharmacodynamic Marker of Tacrolimus Immunosuppression in Renal Transplant Recipients  at  AST Annual Scientific Exchange on 12/2/11 in San Antonio, TX ( Verbal  presentation and Poster-P-6)
  14. Tornatore KM, Brazeau D, Gundroo GA, Venuto RC. Racial Influence on ABCB1 Gene Expression in Peripheral Blood Mononuclear Cells in Stable Renal Transplant Recipients at 2011 Annual Meeting of American Society of  Nephrology on 11/10/11, Philadelphia, PA; JASN October 2011  (Poster: Abstract # 22868).
  15. Tornatore KM, Minderman H, O'Louglin K, Shan G, Wilding G, Venuto RC. Pharmacodynamic Assessment of NFAT Nuclear Localization During tacrolimus Immunosuppression in Renal Transplant Recipients.(Poster) 112thAnnual Meeting of American Society of Clinical Pharmacology & Therapeutics. Dallas, TX (Poster: Abstract LB1-6; March 3, 2011).
  16. Tornatore KM, Minderman H, O'Loughlin K, Gray V, Attwood K, Wilding G, Venuto RC. Assessment of NFAT Nuclear Localization as a Pharmacodynamic Endpoint of Tacrolimus Immunosuppression in Stable Renal Transplant Recipients ;American Society of Transplantation Annual Scientific Exchange 2010; Orlando, FL(Platform & Poster: Abstract #68; October 23, 2010).
  17. Pendyala P, Sudchada P, Venuto R, Gray V, Gundroo A, Attwood K, Wilding G, Tornatore K.   Comparison of Carefully Measured Creatinine to Clearance (CrCl) to Estimated Glomerular F iltration Rate (eGFR) in Stable Renal Transplant Recipients.  American Transplant Congress 2010 San Diego, CA   American Journal of Transplantation 11:4 April 2010  (Poster: Abstract # 1729; May 4, 2010).
  18. Tornatore K, Sudchada P, DiFrancesco R, Gundroo A, Gray V, Attwood K, Wilding G, Venuto R. Mycophenolic Acid and Metabolite Pharmacokinetics in African American (AA) and Caucasian (C) Renal Transplant Recipients receiving Enteric Coated Mycophenolic Sodium and Mycophenolate Mofetil American Transplant Congress 2010 San Diego, CA American Journal of Transplantation 11:4 April 2010 (Poster: Abstract # 874; May 1, 2010).
  19. Tornatore K, Sudchada P, Gundroo A, Gray V, Attwood K, Wallace P, Venuto R.  Time Dependent Pharmacodynamic Responses of T Regulatory Cells in Stable African American and Caucasian Renal Transplant Recipients.  American Transplant Congress 2010 San Diego, CA American Journal of Transplantation 11:4 April 2010 (Poster:  Abstract #1680, May 4, 2010)
  20. Tornatore KM, Sudchada P, DeFrancesco RA, Gundroo A, Gray V, Attwood K, Wilding G, Venuto RC: Comparison of Mycophenolic Acid Pharmacokinetics in African American and Caucasian Renal Transplant Recipients Receiving Mycophenolate Mofetil and Enteric Coated Mycophenolic Sodium; presented at 2009 Annual Meeting of American Society of  Nephrology on 10/29/09 J Am Soc Nephrol   2009; (Abstract #TH-PO1017;Poster).
  21. Nainani N, Patel N, Murray B, Zachariah M, Gundroo A, Blessios G, Tornatore K, Weber-Shrikant E, Venuto R.  Alemtuzumab Induction Followed by Steroid Free, Low Dose Calcineurin Inhibitor Maintainence Immunosuppression in Renal Transplant Recipients-2 year Follow Up.   (Poster) ASN Renal Week 2009, San Diego, CA; J Am Soc Nephrol   2009 (Poster #: TH-PO985; 10/29/10)
  22. Gundroo A, Mustafa R, Tahir N, Singh N, Tornatore K, Wallace P, Venuto R.  Early Recovery of Cytomegalovirus (CMV) Specific CD8+ Lymphocytes and Decreased Incidence of CMV Infection in Renal Transplant Recipients Induced with Alemtuzuab (CAM1H)  (Poster) ASN Renal Week 2009, San Diego, CA; J Am Soc Nephrol   2009 (Poster #:TH-PO966, 10/29/09)
  23. Damodor A, Bhatnagar J, Zachariah M, , Tornatore K, Weber-Shrikant E, Gundroo A, Panesar M, Venuto R: Aggressive Immunosuppression Benefits Post-transplant Glomerulonephritis; presented at 2009 Annual meeting of American Society of Transplantation on 6/2/09; Amer. J. Transplant; 2009:9:suppl 2: pg 684  (Abstract #1788;Poster).
  24. Tornatore KM,  Dole K,  DiFrancesco R, Gillis KA,  Leca N, Gundroo A, Venuto RC, Gender Differences in Cyclosporine Pharmacokinetics in Stable African American and Caucasian Renal Allograft Recipients; presented at 2009 Annual meeting of American Society of Transplantation on 5/31/09 Amer. J. Transplant; 2009:9:suppl 2: pg 496 (Abstract #1084; Poster).
  25. Tornatore KM, DiFrancesco R, Sudchada P, Gundroo A, Minderman H, O'Loughlin K, Wilding G, Danison R,Venuto RC, Assessment of P-glycoprotein in Peripheral Mononuclear Cells in African American and Caucasian Renal Transplant Recipients During Chronic cyclosporine Therapy; presented at 2009 Annual Meeting of American Society of Clinical Pharmacology and Therapeutics on March 21, 2009; Clin. Pharmacol.Ther. 2009: 85:suppl 1:Feb 2009 page S76 (Poster: PIII-24) .
  26. Tornatore KM, Sudchada P,Brazea DA,Venuto RC. Time Dependent Expression of MRP-2 in Peripheral Mononuclear Cells in African American and Caucasian Renal Transplant Recipients; presented at 2009 Annual Meeting of American Society of Clinical Pharmacology and Therapeutics on March 21 2009 ; Clin. Pharmacol.Ther. 2009: 85:suppl 1:Feb 2009 page S76 (Poster: PIII-25).
  27.  Patel N, Nainani N, Murray BM, Gundroo A, Blessios G, Tornatore, KM, Venuto, RC. Effect of Steroid Avoidance and Low Dose Calcinuerin-Inhibitor Immunosuppression on Progression of Chronic Allograft Nephropathy (CAN) Assessed by Surveillance Biopsy;  presented at 2008 Annual Meeting of American Society of Nephrology  2008;19: November 2008; J Am Soc Nephrol   2008;19: November 2008. ( Poster-SA-PO2571)
  28. Nainani N, Patel N, Rahman M, Tahir N, Murray B, Gundroo A, Blessions, G, Tornatore, K , Venuto R; Effect of Steroid Free Mainatenance Immunosuppression Protocol on Progression of Chronic Allograft Nephropathy; 2008 American Transplant Congress in Concurrent Session 58: Kidney Immunosuppression: Steroid Minimization June 3, 2008; Amer. J. Transplant. 2008:8:5: (Abstract #457-Platform).
  29. Sudchada P, Gundroo A, Donneally J, DeFrancesco R, Hochreiter J, Venuto R, Tornatore KM: Influence of Cyclosporine Exposure on the Pharmacokinetics of Mycophenolic Acid in Renal Transplant Recipients.  June 2, 2008; Amer. J. Transplant. 2008:8:5:.(Abstract #1562-Poster)
  30. Sudchada P, Brazeau,D, Dole K., Venuto RC, Tornatore KM; Quantitative real-time PCR Analysis of MRP-2 Expression in Peripheral Mononuclear Cells: Clin. Pharmacol.Ther 2008:82:3 (Poster).
  31. Singh N, Nainani N, Qazi, Y, Murray B, Gundroo A, Blessions G, Tornatore K, Venuto, R: Outcomes of Alemtuzumab Induction in High Risk Renal Transplant Recipients. 39th Annual Meeting of American Society of Nephrology; San Francisco, CA.  November 2, 2007; J Am Soc Nephrol ; November 2, 2007  (Poster-PO 636).
  32. Tornatore KM, Dole K,  Zack J, DeFrancesco R, Gillis K, Leca N, Gundroo A, Venuto RC. Cyclosporine Gender Differences with 12 hour Pharmacokinetic Analysis in Stable Renal Allograft Recipients. 39th Annual Meeting of American Society of Nephrology ; San Francisco, CA; November 2, 2007; J Am Soc Nephrol ; November 2, 2007 (Poster-612).
  33. J. M. Donnelly, S. A. Vannozzi, R. DiFrancesco, K. M. Tornatore. Comparison of Cyclosporine Concentrations in Renal Transplant Recipients(RTR) during Pharmacokinetic Evaluation using Two Assays: Turboflow™ versus Fluorescence Polarimetry Immunoassay. AACC, San Diego,CA July 18, 2007.
  34. Singh N, Gundroo A, Murray B, Qazi, Y, Hassan M,  Khalil F, Blessios G, Tornatore K, Venuto RC. Maintenance Steroid Free Campath-1H Induction Regimen Reduces Metabolic Complications. American Transplant Congress; San Francisco, CA; May 7, 2007. . Amer. J. Transplant. 2007:7:2:444.(Poster-#1458).
  35. Qazi, Y, Singh N, Gundroo A, Khalil F, Hassan M, Murray B, Blessios G, Tornatore K, Venuto RC.One year Results of Alemtuzumab Induction, Calcineurin Minimization Protocol in Renal Transplant Recipients Monitored by Surveillance Biopsies. American Transplant Congress; San Francisco, CA; May 7, 2007; . Amer. J. Transplant. 2007:7:2:444.(Poster-#1159).
  36. Sudchada P, Dole K, Zack J, Leca N, Gundroo A,, Venuto RC, Tornatore KM. Influence of Steroid Use and Gender on Mycophenolic Acid Pharmacokinetics Post-Renal Transplant.  American Transplant Congress. San Francisco, CA;  May 7, 2007. Amer. J. Transplant. 2007:7:2:449.(Poster-#1179).
  37. Sudchada P, Dole K, Zack J,  Leca N,  Gundroo A, Venuto RC, Tornatore KM. Influence of race, steroid use and Renal function on Mycophenolic Acid Pharmacokinetics in Renal Transplant Recipients. American Transplant Congress. San Francisco, CA; May 7, 2007:7:2:449. Amer. J. Transplant. 2007:7:2:449.(Poster-#1172).
  38. Sudchada P,  Dole K., Leca N, Gundroo A, Venuto RC, Tornatore KM.Influence of Race and Steroid Use on Mycophenolic Acid Pharmacokinetics Post- Renal Transplant. 108th Annual Meeting of American Society for Clinical Pharmacology and Therapeutics,Anaheim, CA; March 2007; Clin. Pharmacol.Ther. 2007:81:2(Poster).
  39. Okusanya O.O,  Dole K, Zack J, Forrest A, Gundroo A, Leca N, Venuto RC, Tornatore KM. Population Pharmacokinetic Model of Mycophenolic Acid and its Metabolite-Mycophenolic Acid Glucuronide in Long Term Renal Transplant Patients using Monte CArlo Parametric Expectation Maximization.  108thAnnual Meeting of American Society for Clinical Pharmacology and Therapeutics,Anaheim, CA; March 2007; Clin. Pharmacol.Ther. 2007:81:2(Poster).
  40. Tornatore, KM, Brazeau D, Dole K, Gillis KA, Lecca N, Yassa S, Venuto RC. Impact of Gender, Race and Time on MDR-1 Gene Expression in Stable Renal Transplant Recipients.108th Annual Meeting of American Society for Clinical Pharmacology and Therapeutics, Anaheim, CA; March 2007; Clin. Pharmacol.Ther. 2007:81:2(Poster).
  41. Tornatore KM, Brazeau  D, Wilding G, Dole K, Venuto RC; Integration of Drug Transporter Expression and Metabolic Genotypes with Cyclosporine(CYA) Pharmacokinetics(PK) in Renal Transplant recipients (RTR); 39th Annual Meeting of American Society of Nephrology; San Diego, CA; November 17,  2006; J. American Soc. Nephrology 2006:17:564A (Poster: Abstract F-PO1085).